folligen has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
Studies (folligen) | Trials (folligen) | Recent Studies (post-2010) (folligen) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
---|---|---|---|---|---|
5 | 0 | 0 | 6,010 | 10 | 772 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kéri, G; Nicholson, RI | 1 |
1 other study(ies) available for folligen and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Mammary Neoplasms, Experimental; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Time Factors; Uterus | 1992 |